Literature DB >> 3689367

Butryic acid analogues augment gamma globin gene expression in neonatal erythroid progenitors.

S P Perrine1, B A Miller, M F Greene, R A Cohen, N Cook, C Shackleton, D V Faller.   

Abstract

The gamma----beta globin gene switch in humans is normally on a set developmental clock but is delayed in infants of diabetic mothers. We cultured cord blood erythroid progenitors and assayed globin produced in the presence and absence of metabolites that are elevated in such infants. Analogues of butyric acid at supranormal concentrations significantly augmented gamma and inhibited beta globin expression. The uptake of alpha-amino-n-butyric acid into colony-derived erythroblasts was increased in the presence of supranormal insulin. These findings suggest that elevated levels of alpha-amino-n-butyric acid and insulin in the developing fetus delay the globin switch and may offer potential for augmenting gamma globin expression in the beta globin chain diseases.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3689367     DOI: 10.1016/0006-291x(87)90932-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.

Authors:  Susan P Perrine; Olivier Hermine; Trudy Small; Felipe Suarez; Richard O'Reilly; Farid Boulad; Joyce Fingeroth; Melissa Askin; Arthur Levy; Steven J Mentzer; Massimo Di Nicola; Alessandro M Gianni; Christoph Klein; Steven Horwitz; Douglas V Faller
Journal:  Blood       Date:  2006-11-21       Impact factor: 22.113

2.  Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching.

Authors:  S P Perrine; A Rudolph; D V Faller; C Roman; R A Cohen; S J Chen; Y W Kan
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

Review 3.  Manipulation of Developmental Gamma-Globin Gene Expression: an Approach for Healing Hemoglobinopathies.

Authors:  Vigneshwaran Venkatesan; Saranya Srinivasan; Prathibha Babu; Saravanabhavan Thangavel
Journal:  Mol Cell Biol       Date:  2020-12-21       Impact factor: 4.272

4.  Haptoglobin development in newborn infants from diabetic mothers.

Authors:  P Borgiani; F Gloria-Bottini; G Gerlini; N Lucarini; A Amante; E Bottini
Journal:  Experientia       Date:  1994-07-15

5.  Cis-vaccenic acid induces differentiation and up-regulates gamma globin synthesis in K562, JK1 and transgenic mice erythroid progenitor stem cells.

Authors:  Idowu A Aimola; Hajiya M Inuwa; Andrew J Nok; Aisha I Mamman; James J Bieker
Journal:  Eur J Pharmacol       Date:  2016-02-12       Impact factor: 4.432

6.  MBD2 contributes to developmental silencing of the human ε-globin gene.

Authors:  Jeremy W Rupon; Shou Zhen Wang; Merlin Gnanapragasam; Stefanos Labropoulos; Gordon D Ginder
Journal:  Blood Cells Mol Dis       Date:  2011-02-04       Impact factor: 3.039

7.  Fetal haemoglobin levels in adult type 1 (insulin-dependent) diabetic patients.

Authors:  P Diem; P Mullis; A Hirt; J J Schuler; W Bürgi; K A Zuppinger; A Teuscher
Journal:  Diabetologia       Date:  1993-02       Impact factor: 10.122

8.  5'-flanking sequences mediate butyrate stimulation of embryonic globin gene expression in adult erythroid cells.

Authors:  J G Glauber; N J Wandersee; J A Little; G D Ginder
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

9.  Hydroxyurea responsiveness in β-thalassemic patients is determined by the stress response adaptation of erythroid progenitors and their differentiation propensity.

Authors:  Farzin Pourfarzad; Marieke von Lindern; Azita Azarkeivan; Jun Hou; Sima Kheradmand Kia; Fatemehsadat Esteghamat; Wilfred van Ijcken; Sjaak Philipsen; Hossein Najmabadi; Frank Grosveld
Journal:  Haematologica       Date:  2012-10-25       Impact factor: 9.941

10.  The effect of histone deacetylase inhibitors on AHSP expression.

Authors:  Mohammad Ali Okhovat; Katayoun Ziari; Reza Ranjbaran; Negin Nikouyan
Journal:  PLoS One       Date:  2018-02-01       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.